Rosandra Kaplan: T cell and myeloid populations that contribute to GD2 CART expansion
Rosandra Kaplan, Senior Investigator Physician Scientist Pediatric Oncologist at National Cancer Institute (NCI), on LinkedIn:
“What a perfect holiday gift to see this manuscript of our clinical trial of GD2 CART in Osteosarcoma and Neuroblastoma patients published!
This collaborative work defines T cell and myeloid populations that contribute to GD2 CART expansion.
In honor of the brave patients and their families, especially thinking of you all during the holiday season who chose to partner with us and despite their medical challenges help shed the light on the path for future patients.
Grateful to such a terrific group Sabina Kaczanowska, Sneha Ramakrishna, CATHERINE ‘Lynn’ Hedrick Crystal, Mackall National Cancer Institute (NCI), Stanford University School of Medicine, National Institutes of Health (NIH), Intramural Research Program (IRP), NIH Clinical Center (CC) Foundation for the National Institutes of Health.”
Visit the article website.
Source: Rosandra Kaplan/LinkedIn